Functional properties of leptin receptor isoforms: Internalization and degradation of leptin and ligand-induced receptor downregulation

Diabetes

Volumn 48, Issue 2, 1999, Pages 279-286

  Uotani, Shigeo ^a,b   Bjørbæk, Christian ^a   Tornøe, Jens ^a   Flier, Jeffrey S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0033008075     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.2.279     Document Type: Article

References (62)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and ils human homologue. Nature 372:425-1132, 1994
2. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: the tale of an obesity gene. Diabetes 45:1455-1402, 1906
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Bonne T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
4. Halaas H, Gajiwala K, Maffei M, Cohen S, Chait B, Rabinowitz D, Lallone R, Burley S, Friedman JS: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
5. Campfield L, Smith F, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-548, 1995
6. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997
7. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263-1271, 1995
8. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495, 1996
9. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
10. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401, 1998
11. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MR, Skoda RC: Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 93:6231-6235, 1996
12. Elmquist JK, Bjørbæk C, Ahima RS, Flier JS, Saper CB: Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 395:535-547, 1998
13. Fei H, Okano HJ, Li C, Lee G-H, Zhao C, Darnell R, Friedman JM: Anatomic localization of alternatively spliced leptin receptors (OBR) in mouse brain and other tissues. Proc Natl Acad Sci U S A 94:7001-7005, 1997
14. Golden PL, Maccagnan TJ, Pardridge WM: Human blood-brain barrier leptin receptor binding and endocytosis in isolated human brain microvessels. J Clin Invest 99:14-18, 1997
15. Bjørbæk C, Elmquist JK, Michl P, Anima RS, van Bueren A, McCall AL, Flier JS: Expression of leplin receptor isoforms in rat brain microvessels. Endocrinology 139:3485-3491, 1998
16. Iida M, Murakami T, Yamada M, Sei M, Kuwajima M, Mizuno A, Noma Y, Aono Y, Shima K : Hyperleptinemia in chronic renal failure. Horm Metab Res 28:724-727, 1996
17. Sharma K, Considine RV, Michael B, Dun SR, Weisberg LS, Kurnik BR, Kurnik PB, O'Connor J, Sinha M, Caro JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980-1985, 1997
18. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M: Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82:847-850, 1997
19. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, Lai CF, Tartaglia LA: The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A 93:8374-8378, 1996
20. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97, 1996
21. Bjørbæk C, Uotani S, da Silva B, Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272:32686-32695, 1997
22. Considine R, Sinha MK, Heiman M, Kriaticiunas A, Stephens TW, Nyce MR, Ohannesian P, Marco CC, Mckee L, Bauer TL, Caro JF: Senun immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 334:292-295, 1995
23. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kem PS, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995
24. Wiley HS, Cunningham DD: The endocytotic rate constant: a cellular parameter for quantitating receptor-mediated endocytosis. J Biol Chem 257:4222-4229, 1982
25. Paccaud JP, Saddle K, Carpentier JL: Internalization of the human insulin receptor: the insulin-independent pathway. J Biol Chem 267:13101-13106, 1992
26. Carpentier JL, Sawano F, Geiger D, Gorden P, Perrelet A, Orci L: Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates. J Cell Physiol 138:519-526, 1989
27. Heldin CH, Wasteson A, Westermark B: Interaction of platelet-derived growth factor with its fibroblast receptor demonstration of ligand degradation and receptor modulation. J Biol Chem 257:4216-4221, 1982
28. Mori S, Claesson-Welsh L, Heldin CH: Identification of a hydrophobic region in the carboxyl terminus of the platelet-derived growth factor β-receptor that is important for ligand-mediated endocytosis. J Biol Chem 266:21158-21164, 1991
29. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, Baumann H: Leptin receptor action in hepatic cells. J Biol Chem 272:16216-16223, 1997
30. Yamashita T, Murakami T, Iida M, Kuwajima M, Shima K: Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes 46:1077-1080, 1997
31. Rosenblum CI, Tota M, Cully D, Smith T, Collum R, Qureshi S, Hess JF, Phillips MS, Hey PJ, Vongs A, Fong TM, Xu L, Chen HY, Smith RG, Schindler C, Van der Ploeg LH: Functional STAT 1 and 3 signaling by the lepun receptor (OB-R): reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology 137:5178-5181, 1996
32. Mukherjee S, Ghosh RN, Maxfield FR: Endocytosis. Physiol Rev 77:759-803, 1997
33. Marks MS, Woodruff L, Ohono H, Bonifacino JS: Protein targeting by tyrosine-and di-leucine-based signals: evidence for distinct saturable components. J Cell Biol 135:341-354, 1996
34. Vincent V, Goffin V, Rozakis-Adcock M, Momon JP, Kelly PA: Identification of cytoplasmic motifs required for short prolactin receptor internalization. J Biol Chem 272:7062-7068, 1997
35. King APJ, Tseng MJ, Logsdon CD, Billestrup N, Carter-Su C: Distinct cytoplasmic domains of the growth hormone receptor are required for glucocorticoid- and phorbol ester-induced decreases in growth hormone (GH) binding: these domains are different from that reported for GH-induced receptor internalization. J Biol Chem 271:18088-18094, 1996
36. Suzuki K, Suzuki S, Saito Y, Ikebuchi H, Terao T: Human growth hormone-stimulated growth of human cultured lymphocytes (IM-9) and its inhibition by phorbol diesters through downregulation of the hormone receptors: possible involvement of phosphorylation of a 55,000 molecular weight protein associated with the receptor in the downregulation. J Biol Chem 265:11320-11327, 1990
37. King AP, Carter-Su C: Dexamethasone-induced antagonism of growth hormone (GH) action by downregulation of GH binding in 3T3-F442A fibroblasts. Endocrinology 136:4796-4803, 1995
38. Posner BI, Khan MN, Bergeron JJM: Endocytosis of peptide hormones and other ligands. Endocr Rev 3:280-298, 1982
39. Heldin C-H: Dimerization of cell surface receptors in signal transduction. Cell 80:21.3-223, 1995
40. Genty N, Paly J, Edery M, Kelly PA, Djiane J, Salesse R: Endocytosis and degradation of prolactin and its receptor in Chinese hamster ovary cells stably transfected with prolactin receptor cDNA. Mol Cell Endocrinol 99:221-228, 1994
41. Augustine EC, Kensinger RS: Endocytosis and degradation of ovine prolactin by Nb2 lymphoma cells: characterization and effects of agents known to alter prolactin-induced mitogenesis. Endocrinology 127:200-210, 1990
42. Husman B, Gustafsson JA, Andersson G: Receptor-mediated endocytosis and degradation of bovine growth hormone in rat liver. Mol Cell Endocrinol 59:13-25, 1988
43. 125I-human growth hormone in cultured human lymphocytes: a quantitative morphological and bio-chemical study. J Cell Biol 87:360-369, 1980
44. Anderson RG, Brown MS, Goldstein JL: Role of the coated endocytic vesicle in the uptake of receptor-bound low-density lipoprotein in human fibroblasts. Cell 10:351-364, 1977
45. Backer JM, Shoelson SE, Haring E, White MF: Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. J Cell Biol 115:1535-1545, 1991
46. Roth A, Kreienkamp HJ, Meyerhof W, Richter D: Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and intemalization. J Biol Chem 272:23764-23774, 1997
47. Liu JP: Protein phosphorylation events in exocytosis and endocytosis. Clin Exp Pharmacol Physiol 24:611-618, 1997
48. Shiratori T, Miyatake S, Ohono H, Nakaseko C, Isono K, Bonifacino JS, Saito T: Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6:583-589, 1997
49. Davis CG, Goldstein JL, Sudhof TC, Anderson RG, Russsel DW, Brown MS: Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature 326:760-765, 1987
50. Murakami T, Yamashita T, Iida M, Kuwajima M, Shima K: A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun 231:26-29, 1997
51. Frederich R, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314, 1995
52. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996
53. Mantzoros C, Flier JS, Lesen MD, Brewerton TD, Jimerson DC: Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab 82:1845-1851, 1997
54. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2:589-593, 1996
55. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996
56. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 94:8878-8883, 1997
57. Broadwell RD, Sofroniew MV: Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp Neurol 120:24:5-263, 1993
58. + channels in pancreatic β-cells. Diabetes 46:1087-1093, 1997
59. Muoio DM, Dohn GL, Fiedorek FT Jr, Tapscott EB, Coleman RA: Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46:1360-1363, 1997
60. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA: Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100:2858-2864, 1997
61. Soyka LF, Crawford JD: Antagonism by cortisone of the linear growth induced in hypopituitary patients and hypophysectiomized rats by human growth hormone. J Clin Endocrinol Metab 25:469-475, 1965
62. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B: Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 46:717-719, 1997